Search for: "Patricia J. Zettler" Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2019, 9:30 pm by Benjamin Barsky
FDA’s current regulatory approval process narrowly focuses on clinical trial data to evaluate the health impact of drugs, overlooking broader public health effects such as those created by opioid addiction, according to a recent paper by Patricia J. [read post]
28 Apr 2019, 9:02 pm by Series of Essays
Sherkow, a professor at New York Law School; and Patricia J. [read post]
6 Apr 2023, 9:05 pm by Victoria Hawekotte
EDITOR’S CHOICE In an essay in The Regulatory Review, Patricia J. [read post]
9 Sep 2022, 9:04 pm by Katie Cohen
Although states have broader latitude to regulate the practice of medicine directly, they cannot impose policies that conflict with FDA requirements, according to Patricia J. [read post]
2 Nov 2017, 9:30 pm by Sarah Madigan
WHAT WE’RE READING THIS WEEK In a forthcoming paper for the Boston College Law Review, Patricia J. [read post]
4 Feb 2021, 9:05 pm by Max Masuda-Farkas
FLASHBACK FRIDAY In an essay in The Regulatory Review, Patricia J. [read post]
11 Oct 2019, 9:05 pm by Milad Emamian
How Regulation Affects the Opioid Crisis In a paper published in the Food and Drug Law Institute’s Food and Drug Law Journal, Patricia J. [read post]